why choose us

First received: October 23, 2023

Clinical Trial: Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Cardiorenal Syndrome

Study Type: INTERVENTIONAL


Official Title: Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

Brief Summary: The overall objective of this study is to determine whether the addition of SGLT2 inhibitors to usual care during acute heart failure shortens the time to symptomatic improvement and kidney function recovery.The study aims to assess feasibility, acceptability, and impact on decongestion and early biomarkers of kidney injury.

Read more